|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit | ||||||||||||||||||||
| Securities held to maturity, net | ||||||||||||||||||||
| Available for Sale, Fair Value | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Federal Home Loan Bank of New York and other stock, at cost | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholder’s Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Advances from borrowers for taxes and insurance | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholder’s equity: | ||||||||||||||||||||
| Common stock; par value $.01, 100,000,000 shares authorized; 17,906,285 (September 30, 2023), 15,930,976 (December 31, 2022) shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Unallocated common stock held by the Employee Stock Ownership Plan | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholder’s equity | ||||||||||||||||||||
| Total liabilities and stockholder’s equity | ||||||||||||||||||||
Loading...
